Status:
COMPLETED
Efficacy and Safety of Obturator Nerve Block During Transurethral Resection on Non-muscle Invasive Intermediate and High Risk Lateral Wall Bladder Tumours
Lead Sponsor:
Ankara Training and Research Hospital
Conditions:
Bladder Cancer Stage 0
Bladder Cancer Stage I
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
In this prospective randomized controlled study, the effects of obturator nerve block (ONB) on obturator reflex, incomplete resection, perforation, tumor recurrence and progression, presence of muscle...
Detailed Description
Bladder cancer is among the ten most common types of cancer in the world, with about 550,000 new cases per year. According to GLOBOCAN (Global Cancer Incidence, Mortality and Prevalence) data, bladder...
Eligibility Criteria
Inclusion
- Lateral wall intermediate and high risk non-muscle invasive bladder cancer
Exclusion
- Low risk non-muscle invasive bladder cancer
- Contraindications for spinal anesthesia
- History of allergy to local anesthetic agents
- Coagulopathy
- Neuromuscular diseases affecting the central nervous system
- Obturator nerve injury
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT04885309
Start Date
January 1 2018
End Date
April 1 2021
Last Update
May 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara Training and Research Hospital
Ankara, Altindag, Turkey (Türkiye), 06230